A detailed history of Lmr Partners LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Lmr Partners LLP holds 23,361 shares of PRCT stock, worth $2.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,361
Previous 14,289 63.49%
Holding current value
$2.17 Million
Previous $872,000 114.56%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$56.31 - $84.99 $510,844 - $771,029
9,072 Added 63.49%
23,361 $1.87 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $653,435 - $988,655
14,289 New
14,289 $872,000
Q4 2021

Feb 14, 2022

SELL
$24.6 - $46.29 $806,880 - $1.52 Million
-32,800 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $1.18 Million - $1.38 Million
32,800 New
32,800 $1.25 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.13B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.